The global gastrointestinal stents market reached a value of US$ 386.3 Million in 2019. Gastrointestinal stents refer to cylindrical tube grafts inserted in the body to preclude blockages in the gullet, stomach, and small intestine. These stents are manufactured using the semirigid, plastic, or self-expanding mesh that are mainly placed in bile ducts, esophagus, or colon, for removing obstruction and reducing the pressure caused by inflammation. Gastrointestinal stents commonly include colonic, duodenal, biliary, pancreatic, and esophageal stents.       

Request for a free sample copy of this report: https://www.imarcgroup.com/gastrointestinal-stents-market/requestsample

Looking forward, IMARC Group expects the market to reach a value of US$ 483.2 Million by 2025, exhibiting a CAGR of 3.8% during 2020-2025. The high prevalence of colorectal cancer, along with the rising inclination towards minimally invasive surgeries, is primarily driving the market growth. Furthermore, the increasing geriatric population who are prone to bowel ailment, diverticulosis, and gastrointestinal malignancies, is also propelling the market for gastrointestinal stents. Moreover, the rising demand for technologically advanced biodegradable and nitinol material-based stents is further augmenting the market growth. Additionally, the increasing use of self-expandable metal stents for the treatment of anastomotic leaks and perforation leads is further expected to propel the market for gastrointestinal stents.

Explore full report with table of contents: https://www.imarcgroup.com/gastrointestinal-stents-market 

Breakup by Product Type:

• Biliary Stents
• Duodenal Stents
• Colonic Stents
• Pancreatic Stents
• Esophageal Stents

Breakup by Technology Type:

• Anti-Migratory Stents
• Drug-Eluting Stents
• Radioactive Stents
• Anti-Reflux Stents
• Shape-Modified Stents
• Others

Breakup by Material:

• Plastic Stents
• Self-Expanding Metal Stents
  • Stainless Steel Stents
  • Nitinol Stents
  • Others
• Covered Self-Expandable Metallic Stents
• Biodegradable or Drug Eluting Stents

Breakup by End User:

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centres
• Others

Breakup by Region:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Becton, Dickinson and Company, Boston Scientific Corporation, Cantel Medical Corporation, Conmed Corporation, Cook Group Incorporated, ELLA-CS, S.R.O., Hobbs Medical Inc., Merit Medical Systems Inc., Olympus Corporation, Taewoong Medical Co. Ltd., etc.

Note: As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

If you want to need latest primary and secondary data (2020-2025) with Cost Module, Business Strategy, Distribution Channel, etc. click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Media Contact
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: Send Email
Phone: +1 6317911145
Address:30 N Gould St, Ste R
City: Sheridan
State: WY 82801
Country: United States
Website: https://www.imarcgroup.com/